AURORA-A, the expression of which was increased in the pathway of molecular mechanism of cancer after 1 h (Figure S6), 24 h (Figure S57) and 8 days (Figure S58) of TPA treatment, regulates genomic instability and tumorigenesis through cell cycle dysregulation and BRCA2 suppression [60]. The gene discussed is BRCA2; the disease is cancer.